RPH-030

· R-Pharm

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPH-030, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI [Phase 1]

See pricing